go to home page | go to navigation | go to page content | go to contact | go to sitemap
Home > Library > EU: eHealth Monthly Focus on VPHOP > EU: eHealth Monthly Focus on VPHOP

practice EU: eHealth Monthly Focus on VPHOP

EU: eHealth Monthly Focus on VPHOP

239 Visits |
starstarstarempty starempty starIn order to vote, you need to be logged in!
Published date
29 February 2012
Country
Belgium, Czech Republic, France, Germany, Iceland, Italy, Netherlands, Sweden, Switzerland, United Kingdom, EU Institutions
Domain
eHealth
Languages
English
Author
VPHOP project
Publisher
European Commission, Directorate-General for Information Society and Media
License of the document
Other
Submitted By
ePractice Editorial Team (EUROPEAN DYNAMICS SA) | Belgium
Complete title:
eHealth Monthly Focus on Osteoporotic Virtual Physiological Human (VPHOP) - Musculoskeletal ageing, a technological renaissance - Using advanced imaging and physiological modelling technologies to predict the risk of bone fracture in osteoporotic patients

Description (short summary):
VPHOP or Osteoporotic Virtual Physiological Human is a European osteoporosis research project within the framework of the Virtual Physiological Human (VPH) initiative.

The goal of the VPHOP project is to develop, validate and deploy the next generation of personalised multiscale modelling technology, which could radically change the way osteoporotic fractures are dealt.

This innovative technology is based on conventional and modern diagnostic imaging methods, plus daily activity monitoring that makes it possible, in a clinical setting, to assess for each patient individually:

  • the strength of his/her bones;
  • how this strength is likely to change over time; and,
  • the probability that he/she will overload his/her bones during daily life.

In fact, the world‐leading predictive models at the body, organ, tissue, and cell levels developed within the project by various academic partners are able to predict the loads on the bones and the progressive changes to the tissue properties, the structure and, ultimately, the fracture risk over time, as well as how treatments, both pharmacological and interventional, might modify these risks.

Number of pages: 2

Multimedia Content Select a Tab

There isn't any SlideShare for this library
There isn't any image for this library
There isn't any Video for this library
In order to send a message you need to be registered at least one month and have earned more than 150 kudos.